In addition, CA9 immunostaining in frozen tumour sections generally colocated with regions of binding of the hypoxic marker, pimonidazole (Fig. 8c), indicating the presence of hypoxic areas in xenograft tumours developed in the CAM assay. This evidence concerns the gene CA9 and neoplasm.